ENTEG start-up Sencilia secured SNN-valorization subsidy for ‘SmartInfuus’-project

Sencilia, a startup company spun out of the Bioinspired MEMS and Biomedical Devices (BMBD) group within the Engineering and Technology Institute (ENTEG) at the University of Groningen, is pioneering IV infusion sensing technology. This innovation enables continuous monitoring of the IV infusion's status, promptly notifying clinicians of any undesirable flow variations in the infusion line. In the SmartInfuus project, Sencilia will partner with the UMCG (University Medical Center Groningen) and the University of Groningen. This strategic alliance harnesses the expertise of these academic groups to expedite both technical and (pre)clinical development, ultimately bringing this technology closer to market availability.

To achieve the compact form factors required for clinical use, the BMBD group's MEMS fabrication expertise, led by Prof. dr. Ajay Kottapalli will be instrumental in miniaturizing the sensors. Subsequently, the sensor technology will undergo testing in a perfused pig kidney model developed by the Surgical Research Laboratory at the UMCG, under the guidance of Prof. dr. Henri Leuvenink.

We congratulate the team for successfully securing project funding and wish them every success with setting up the project.